NOT-CA-17-070: Notice of NCI's Participation on PA-17-132, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)

Notice of NCI's Participation on PA-17-132 "Public Policy Effects on Alcohol, Marijuana, and Other Substance-Related Behaviors and Outcomes (R21)"

Notice Number: NOT-CA-17-070

Key Dates
Release Date: July 18, 2017

Related Announcements

PA-17-132

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PA-17-132, "Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)."

The following changes have been made to reflect NCI's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.273, 93.279, 93.399

Part 2. Section VII. Agency Contacts

The following contacts have been added

Scientific/Research Contact(s)

Carolyn Reyes-Guzman, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7244
Email: [email protected]

Financial/Grants Management Contact(s)

Carol Perry
National Cancer Institute (NCI)
Telephone: 240-276-6282
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Carolyn Reyes-Guzman, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7244
Email: [email protected]